BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30317669)

  • 1. The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis.
    Abbasian M; Mousavi E; Arab-Bafrani Z; Sahebkar A
    J Cell Physiol; 2019 Jun; 234(6):8192-8202. PubMed ID: 30317669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines.
    Dinger TF; Chen O; Dittfeld C; Hetze L; Hüther M; Wondrak M; Löck S; Eicheler W; Breier G; Kunz-Schughart LA
    Theranostics; 2020; 10(17):7599-7621. PubMed ID: 32685007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin Signaling Inhibitors suppress the Tumor-initiating properties of a CD44
    Kim J; Choi KW; Lee J; Lee J; Lee S; Sun R; Kim J
    Int J Biol Sci; 2021; 17(7):1644-1659. PubMed ID: 33994850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.
    Pitule P; Cedikova M; Daum O; Vojtisek J; Vycital O; Hosek P; Treska V; Hes O; Kralickova M; Liska V
    Biomed Res Int; 2014; 2014():432139. PubMed ID: 24864242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.
    Bao B; Azmi AS; Aboukameel A; Ahmad A; Bolling-Fischer A; Sethi S; Ali S; Li Y; Kong D; Banerjee S; Back J; Sarkar FH
    J Biol Chem; 2014 May; 289(21):14520-33. PubMed ID: 24719318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
    Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
    Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
    Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
    Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Validation Study of CD133 as a Reliable Marker for Identification of Colorectal Cancer Stem-Like Cells.
    You CZ; Xu H; Zhao FS; Dou J
    Bull Exp Biol Med; 2024 Jan; 176(3):369-375. PubMed ID: 38340198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzing the Expression of Biomarkers in Prostate Cancer Cell Lines.
    Su CY; Huang GC; Chang YC; Chen YJ; Fang HW
    In Vivo; 2021; 35(3):1545-1548. PubMed ID: 33910833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.
    Chen J; Guo T; Zhang L; Qin LX; Singer S; Maki RG; Taguchi T; Dematteo R; Besmer P; Antonescu CR
    Genes Chromosomes Cancer; 2012 Feb; 51(2):186-95. PubMed ID: 22076958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer.
    Kaida T; Fujiyama Y; Soeno T; Yokota M; Nakamoto S; Goto T; Watanabe A; Okuno K; Nie Y; Fujino S; Yokota K; Harada H; Tanaka Y; Tanaka T; Yokoi K; Kojo K; Miura H; Yamanashi T; Sato T; Sasaki J; Sangai T; Hiki N; Kumamoto Y; Naitoh T; Yamashita K
    PLoS One; 2023; 18(4):e0277395. PubMed ID: 37098074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cancer stem cell-related markers in different stages of colorectal carcinoma patients of Indian origin by immunohistochemistry.
    Chaitra LP; Prashant A; Gowthami CS; Hajira B; Suma MN; Mahesh SS; Manjunath GV; Sheeladevi CS
    J Cancer Res Ther; 2019; 15(1):75-81. PubMed ID: 30880758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
    Joseph C; Arshad M; Kurozomi S; Althobiti M; Miligy IM; Al-Izzi S; Toss MS; Goh FQ; Johnston SJ; Martin SG; Ellis IO; Mongan NP; Green AR; Rakha EA
    Breast Cancer Res Treat; 2019 Apr; 174(2):387-399. PubMed ID: 30554343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer.
    Galizia G; Gemei M; Del Vecchio L; Zamboli A; Di Noto R; Mirabelli P; Salvatore F; Castellano P; Orditura M; De Vita F; Pinto M; Pignatelli C; Lieto E
    Arch Surg; 2012 Jan; 147(1):18-24. PubMed ID: 22250106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
    Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
    Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of CD44 variant 2 upregulation in colorectal cancer.
    Ozawa M; Ichikawa Y; Zheng YW; Oshima T; Miyata H; Nakazawa K; Guan HB; Shiozawa M; Akaike M; Watanabe K; Ota M; Fujii S; Kunisaki C; Ishikawa T; Tanaka K; Akiyama H; Endo I; Taniguchi H
    Br J Cancer; 2014 Jul; 111(2):365-74. PubMed ID: 24921913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44 and CD133 stem cell markers in squamous cell carcinoma of esophagus.
    Gupta P; Rizvi SZ; Lal N; Gupta V; Srivastav AN; Musa O
    Indian J Pathol Microbiol; 2021; 64(3):472-478. PubMed ID: 34341256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.